Marco Costa, MD, PhD


Interventional Cardiology

  • Director, Interventional Cardiovascular and Research and Innovation Centers, University Hospitals
  • Chief Innovation Officer, University Hospitals


  • Gender: Male
  • Online Personal Health Record Available
Marco Costa, MD

Video Library

Education & Training

Medical / Professional School(s)

1994, Universidade Federal de Minas Gerais, Faculdade de Medicina


1994, Internal Medicine - Universidade Federal de Minas Gerais, Faculdade de Medicina


1996, Cardiovascular Disease - Hospital Felicio Rocho


1998, Interventional Cardiology - Hospital Felicio Rocho
2000, Interventional Cardiology - Erasmus Universiteit Faculteit der Geneeskunde

Research Fellowship

1994, Cardiothoracic Anesthesia - Cleveland Clinic


Cardiac Catheterization, Cardiovascular Imaging, Cardiovascular Medicine, Endovascular Procedures, Interventional Cardiology, Optical Coherence Tomography, Percutaneous Valve Repair, Stem Cell Therapy, Structural Heart Disease

Office Locations

UH Case Medical Center
Department of Medicine-Cardiovascular Medicine
11100 Euclid Ave
Cleveland, OH 44106
Get Directions

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2015, Marco Costa, MD, PhD disclosed the following Outside Relationships with Industry:

Abbott Laboratories - Consulting

Boston Scientific Corp - Consulting

Cardiokinetix - Consulting

Cordis Corporation - Consulting

Daiichi-Sankyo - Consulting

Eli Lilly Pharmaceuticals Company - Consulting

Medtronic, Inc. - Consulting

Sanofi-Aventis - Consulting

Scitech Medical, Inc. - Consulting

St Jude Medical, Inc. - Consulting

St. Jude Medical, Inc. - Consulting

Abbott Vascular - Honoraria

Genae Americas - Ownership

Genae Americas - Ownership

StemMed Inc. - Ownership

There is no publicly available rating for this medical professional for one of two reasons: 1) he or she does not see patients or 2) he or she sees patients but has not yet received the minimum number of Patient Satisfaction Reviews. To be eligible for display, we require a minimum of 30 surveys. This ensures that the rating is statistically reliable and a true reflection of patient satisfaction.